160 related articles for article (PubMed ID: 35660138)
1. Hypertrophic pachymeningitis with co-occurrence of anti-neutrophil cytoplasmic antibodies and immunoglobulin G4 seropositivity: Case report and literature review.
Yu XL; Song XW; Guan TR; Dai QD; Zhang Y; Jiang Y
J Neuroimmunol; 2022 Jul; 368():577896. PubMed ID: 35660138
[TBL] [Abstract][Full Text] [Related]
2. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
3. [Orbital apex syndrome due to relapse during steroid tapering in a patient with MPO-ANCA-positive IgG4-related hypertrophic pachymeningitis].
Iwanami M; Ogawa T; Tanaka Y; Hyoudo A; Ueda Y; Miyamoto T
Rinsho Shinkeigaku; 2014; 54(1):52-5. PubMed ID: 24429649
[TBL] [Abstract][Full Text] [Related]
4. Hypertrophic Pachymeningitis with Characteristics of Both IgG4-related Disorders and Granulomatosis with Polyangiitis.
Mori M; Sakai K; Saito K; Nojima T; Mohri M; Matsubara K; Hayashi S; Yamada M
Intern Med; 2022 Jun; 61(12):1903-1906. PubMed ID: 34803104
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin-G4-related hypertrophic pachymeningitis with antineutrophil cytoplasmatic antibodies effectively treated with rituximab.
Popkirov S; Kowalski T; Schlegel U; Skodda S
J Clin Neurosci; 2015 Jun; 22(6):1038-40. PubMed ID: 25861887
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis.
Horino T; Takao T; Taniguchi Y; Terada Y
Clin Rheumatol; 2010 Jan; 29(1):111-3. PubMed ID: 19727912
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.
Bi Z; Shang K; Cao J; Su Z; Bu B; Xu S; Liu C
Biomed Res Int; 2020; 2020():2926419. PubMed ID: 32879880
[TBL] [Abstract][Full Text] [Related]
8. Hypertrophic Pachymeningitis Associated with Myeloperoxidase-anti-neutrophil Cytoplasmic Antibodies Induced by Propylthiouracil.
Koide S; Kitajima K; Yamazaki M; Ichikawa T; Komatsu M
Intern Med; 2023 Jul; 62(13):1951-1955. PubMed ID: 36384900
[TBL] [Abstract][Full Text] [Related]
9. [Atypical headache and facial pain as a result of hypertrophic pachymeningitis in C-ANCA-positive Wegener's granulomatosis].
Kuhn J; Weber M; Hedde JP; Bewermeyer H
Med Klin (Munich); 2005 Apr; 100(4):209-12. PubMed ID: 15834530
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic pachymeningitis associated with antineutrophil cytoplasmic antibody-associated vasculitis: a case series of 15 patients.
Sakairi T; Sakurai N; Nakasatomi M; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
Scand J Rheumatol; 2019 May; 48(3):218-224. PubMed ID: 30394816
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 15 cases with myeloperoxidase antineutrophil cytoplasmic antibody associated hypertrophic pachymeningitis].
Guan WJ; Ding YX; Liu LJ; Li W; Jing LJ; Zhang X; Zhang LJ; Li H; Cheng SH; Liu SY
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):565-569. PubMed ID: 35488609
[TBL] [Abstract][Full Text] [Related]
12. A Case of Hypertrophic Pachymeningitis Associated with Immunoglobulin-G4 and c-ANCA.
Wyrostek S; Chakrabarti S; Baldwin K; Avila JD
Case Rep Neurol; 2019; 11(3):290-294. PubMed ID: 31762760
[TBL] [Abstract][Full Text] [Related]
13. The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients.
Chen H; Zhang W; Jing J; Raza HK; Zhang Z; Zhu J; Liu Y; Cui G; Hua F; Dong L
Neurol Sci; 2019 Feb; 40(2):269-274. PubMed ID: 30377845
[TBL] [Abstract][Full Text] [Related]
14. Adolescent PR3-ANCA-positive hypertrophic pachymeningitis: A case report and review of the literature.
Matsumoto K; Akiyama M; Kajio N; Otomo K; Suzuki K; Nishina N; Kasuya K; Oishi N; Kameyama K; Takeuchi T
Medicine (Baltimore); 2018 Apr; 97(17):e0521. PubMed ID: 29703022
[TBL] [Abstract][Full Text] [Related]
15. Clinical, imaging features and treatment response of idiopathic hypertrophic pachymeningitis.
Yao Y; Xu Y; Li X; Song T; Xu W; Duan Y; Liu Y; Zhang X; Tian DC
Mult Scler Relat Disord; 2022 Oct; 66():104026. PubMed ID: 35868153
[TBL] [Abstract][Full Text] [Related]
16. [A Case of IgG4-related Hypertrophic Pachymeningitis].
Hayashi K; Somagawa C; Hayashi Y; Iwanaga M
No Shinkei Geka; 2018 Dec; 46(12):1103-1109. PubMed ID: 30572308
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic pachymeningitis with anti-neutrophil cytoplasmic antibody (p-ANCA), and diabetes insipidus.
Takuma H; Shimada H; Inoue Y; Ishimura E; Himuro K; Miki T; Nishizawa Y
Acta Neurol Scand; 2001 Dec; 104(6):397-401. PubMed ID: 11903097
[TBL] [Abstract][Full Text] [Related]
18. Hypertrophic Pachymeningitis as a Delayed Complication of Granulomatosis with Polyangiitis.
Kumamoto M; Tomoda K; Furuya Y; Iwasa N; Ueno S; Yoshikawa M; Kimura H
Intern Med; 2016; 55(4):413-7. PubMed ID: 26875970
[TBL] [Abstract][Full Text] [Related]
19. Polycystic subdural hygroma associated with immunoglobulin G4-related intracranial hypertrophic pachymeningitis: a case report.
Ota K; Nakazato Y; Okuda R; Yokoyama R; Kawasaki H; Tamura N; Yamamoto T
BMC Neurol; 2020 Jun; 20(1):228. PubMed ID: 32498716
[TBL] [Abstract][Full Text] [Related]
20. [Hypertrophic pachymeningitis secondary to IgG4-related disease: case report and review of the literature].
Rodríguez-Castro E; Fernández-Lebrero A; López-Dequidt IA; Rodríguez-Osorio X; López-González FJ; Suárez-Peñaranda JM; Arias M
Rev Neurol; 2015 Oct; 61(7):308-12. PubMed ID: 26411275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
